Experimental Therapies for Small Cell Lung Cancer and Acute Myeloid Leukemia Earn Orphan Drug Designation
source: pixabay.com

Experimental Therapies for Small Cell Lung Cancer and Acute Myeloid Leukemia Earn Orphan Drug Designation

According to a story from BioSpace, the biotechnology company Ascentage Pharma announced that two of its investigational treatments have recently received Orphan Drug designation from the US Food and Drug…

Continue Reading Experimental Therapies for Small Cell Lung Cancer and Acute Myeloid Leukemia Earn Orphan Drug Designation
Collaborative Study Highlights the Importance of Proteinuria in Focal Segmental Glomerulosclerosis
source: pixabay.com

Collaborative Study Highlights the Importance of Proteinuria in Focal Segmental Glomerulosclerosis

According to a story from BioSpace, a recent study conducted by the biotechnology company Goldfinch Bio in collaboration with academic partners is highlighting the importance of proteinuria in determining outcomes…

Continue Reading Collaborative Study Highlights the Importance of Proteinuria in Focal Segmental Glomerulosclerosis
RDLA Webinar Provides Vital Updates on Legislation Relevant to the Rare Disease Community
source: pixabay.com

RDLA Webinar Provides Vital Updates on Legislation Relevant to the Rare Disease Community

On October 15th, 2020, the Rare Disease Legislative Advocates (RDLA) held a webinar discussing some of the latest news regarding ongoing legislation that is most relevant to the rare disease…

Continue Reading RDLA Webinar Provides Vital Updates on Legislation Relevant to the Rare Disease Community
No Link Between Human Papillomavirus Vaccine and Autonomic Dysfunction Syndromes
source: pixabay.com

No Link Between Human Papillomavirus Vaccine and Autonomic Dysfunction Syndromes

by Lauren Taylor from In The Cloud Copy The human papillomavirus (HPV) vaccine has been being administered to teens and young adults worldwide for over a decade now. It has…

Continue Reading No Link Between Human Papillomavirus Vaccine and Autonomic Dysfunction Syndromes

Rett Syndrome Treatment TSHA-102 Received Rare Pediatric Disease and Orphan Drug Designations

Recently, gene therapy company Taysha Gene Therapies ("Taysha") announced that its gene therapy candidate, TSHA-102, received both Orphan Drug and Rare Pediatric Disease designations from the FDA. TSHA-102, delivered via…

Continue Reading Rett Syndrome Treatment TSHA-102 Received Rare Pediatric Disease and Orphan Drug Designations
UT Southwestern Expands Diagnostic and Treatment Approaches for Aplastic Anemia, MDS
source: pixabay.com

UT Southwestern Expands Diagnostic and Treatment Approaches for Aplastic Anemia, MDS

What are the best treatments and diagnostic approaches for blood disorders like aplastic anemia and myelodysplastic syndromes (MDS)? The UT Southwestern Medical Center is trying to streamline these options and…

Continue Reading UT Southwestern Expands Diagnostic and Treatment Approaches for Aplastic Anemia, MDS
Experimental Gene Therapy for GM1 Gangliosidosis Earns Rare Pediatric Disease Designation
source: pixabay.com

Experimental Gene Therapy for GM1 Gangliosidosis Earns Rare Pediatric Disease Designation

According to a story from BioSpace, the gene therapy company Axovant Gene Therapies Ltd. recently announced that it has been given Rare Pediatric Disease designation from the US Food and…

Continue Reading Experimental Gene Therapy for GM1 Gangliosidosis Earns Rare Pediatric Disease Designation
Natural History Study on Metachromatic Leukodystrophy To Use Innovative Methodology
source: pixabay.com

Natural History Study on Metachromatic Leukodystrophy To Use Innovative Methodology

As reported in Biospace, the National Organization for Rare Disorders (NORD) has just opened registration for patients to take part in a natural history study on metachromatic leukodystrophy (MLD), a…

Continue Reading Natural History Study on Metachromatic Leukodystrophy To Use Innovative Methodology
FDA Accepts Investigational New Drug Application for Cervical Dystonia Treatment
source: pixabay.com

FDA Accepts Investigational New Drug Application for Cervical Dystonia Treatment

by Lauren Taylor from In The Cloud Copy Cervical dystonia, sometimes called spasmodic torticollis, is a condition in which the affected individual’s neck muscles involuntarily contract which causes the head…

Continue Reading FDA Accepts Investigational New Drug Application for Cervical Dystonia Treatment
Researchers Provide a Better Understanding of sJIA and Still’s Disease
Sourced from publicdomainpictures.net (https://www.publicdomainpictures.net/en/view-image.php?image=275669&picture=chemical-research)

Researchers Provide a Better Understanding of sJIA and Still’s Disease

According to Healio, medical professionals from Boston Children's Hospital have conducted research that provides a better look at systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still's disease. They looked specifically…

Continue Reading Researchers Provide a Better Understanding of sJIA and Still’s Disease
First Patient Dosed in Trial of Hypoparathyroidism Treatment, AZP-3601
DarkoStojanovic / Pixabay

First Patient Dosed in Trial of Hypoparathyroidism Treatment, AZP-3601

Amolyt Pharma has recently announced that they have dosed the first patient in their trial of AZP-3601, a treatment for hypoparathyroidism. According to GlobeNewswire, this treatment will adequately address the…

Continue Reading First Patient Dosed in Trial of Hypoparathyroidism Treatment, AZP-3601
FDA Grants IDE to Test Experimental Device for Pulmonary Arterial Hypertension
source: pixabay.com

FDA Grants IDE to Test Experimental Device for Pulmonary Arterial Hypertension

According to a story from GlobeNewswire, the medical device company SoniVie announced recently that the US Food and Drug Administration (FDA) has granted approval for its Investigational Device Exemption (IDE).…

Continue Reading FDA Grants IDE to Test Experimental Device for Pulmonary Arterial Hypertension